Clinical Trial
Offered by: Nemours Children's
Locations: Jacksonville, Fla.; Pensacola, Fla.
Trial Name
Phase III Randomized Study of Chimeric Antibody 14.18 (Ch14.18) in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue
What is the trial about?
Evaluate an investigational treatment aimed at maintaining or improving your child’s response to previous treatments.
Who can participate?
Children undergoing treatment for high risk neuroblastoma.
What is involved?
Length of study is six months. Tests and procedures performed include: Physical exam; Blood tests; Bone marrow tests; Various scans; Tests of kidney function; Tests of lung and heart function; Urine tests.
Contact Nemours Children's Clinical Trials
Trial Name: Phase III Randomized Study of Chimeric Antibody 14.18 (Ch14.18) in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue
COG#: ANBL0032
(800) 354-5690 Email UsIs a Clinical Trial Right for Your Child?
Learn more about clinical trials and get answers to questions you might have.
Go to FAQs View All Clinical Trials
Nemours has a number of service regions. Selecting your region will help us show you the right contact information and the most relevant content for you.